In Down syndrome, increased interleukin-6 and SOD1; in Fragile X syndrome, elevated FMR1 mRNA and cytokine changes; and in Rett syndrome, increased ammonium and metabolic profile disturbances are observed. This evidence concerns the gene IL6 and fragile X syndrome.